US President Joe Biden yesterday expressed support for a Israel-Gaza ceasefire in a call with Israel’s Prime Minister Netanyahu, and today EU foreign ministers will meet to discuss the conflict, and a biotech company developing medicines that mimic the painkilling effects of cannabis is set to list in London this week. Plus, the FT’s South China correspondent, Primrose Riordan, explains why activists are calling BlackRock “inconsistent” in its ESG commitments. Biden backs ceasefire in Israel-Palestinian conflicthttps://www.ft.com/content/d388d8b4-94ce-49d1-b8ab-df171286fdadEuropeans hamstrung by rifts on Gaza conflicthttps://www.ft.com/content/6c42bcb1-7013-4b74-8526-35ef7fae6f5d?Start-up focused on painkilling effects of cannabis to list in Londonhttps://www.ft.com/content/2952b9c9-f14a-4300-b1ac-d6c6bf5f8c8f?BlackRock accused of ESG inconsistency over Indonesia palm oilhttps://www.ft.com/content/479b9dd2-c738-4310-8b1e-afdfbd3921b0 Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.